Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

[Efficacy of conventional chemotherapy in a primary double-refractory IgM multiple myeloma.]

Innao V, Allegra A, Allegra AG, Musolino C.

Recenti Prog Med. 2019 Jul-Aug;110(7):364-367. doi: 10.1701/3197.31749. Italian.

PMID:
31379372
2.

Mitochondria-Targeted Antioxidant SkQ1 for Gammopathy-Related Corneal Damage.

Innao V, Allegra A, Musolino C.

Am J Ther. 2019 Jul 3. doi: 10.1097/MJT.0000000000001010. [Epub ahead of print] No abstract available.

PMID:
31356345
3.

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials.

Martino M, Rossi M, Ferreri A, Loteta B, Morabito A, Moscato T, Console G, Innao V, Naso V, Provenzano PF, Recchia AG, Gentile M.

Expert Rev Hematol. 2019 Aug;12(8):665-684. doi: 10.1080/17474086.2019.1634541. Epub 2019 Jul 3.

PMID:
31251688
4.

First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials.

Larocca A, Mina R, Offidani M, Liberati AM, Ledda A, Patriarca F, Evangelista A, Spada S, Benevolo G, Oddolo D, Innao V, Cangialosi C, Bernardini A, Musto P, Amico V, Fraticelli V, Paris L, Giuliani N, Falcone AP, Zambello R, De Paoli L, Romano A, Palumbo A, Montefusco V, Hajek R, Boccadoro M, Bringhen S.

Haematologica. 2019 Jun 27. pii: haematol.2019.220657. doi: 10.3324/haematol.2019.220657. [Epub ahead of print]

5.

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network.

Conticello C, Romano A, Del Fabro V, Martino EA, Calafiore V, Sapienza G, Leotta V, Parisi MS, Markovic U, Garibaldi B, Leotta S, Cotzia E, Innao V, Mannina D, Neri S, Musso M, Scalone R, Cangialosi C, Acquaviva F, Cardinale G, Merenda A, Maugeri C, Uccello G, Poidomani M, Longo G, Carlisi M, Tibullo D, Di Raimondo F.

J Clin Med. 2019 Jun 19;8(6). pii: E877. doi: 10.3390/jcm8060877.

6.

Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma.

Allegra A, Innao V, Allegra AG, Pugliese M, Di Salvo E, Ventura-Spagnolo E, Musolino C, Gangemi S.

Int J Mol Sci. 2019 Jun 10;20(11). pii: E2822. doi: 10.3390/ijms20112822. Review.

7.

Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw.

Allegra A, Innao V, Pulvirenti N, Musolino C.

Tohoku J Exp Med. 2019 May;248(1):27-29. doi: 10.1620/tjem.248.27.

8.

Relationship between mitofusin 2 and cancer.

Allegra A, Innao V, Allegra AG, Musolino C.

Adv Protein Chem Struct Biol. 2019;116:209-236. doi: 10.1016/bs.apcsb.2018.11.009. Epub 2018 Dec 27.

PMID:
31036292
9.

Role of the microbiota in hematologic malignancies.

Allegra A, Innao V, Allegra AG, Ettari R, Pugliese M, Pulvirenti N, Musolino C.

Neth J Med. 2019 Feb;77(2):67-80.

10.

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma.

Allegra A, Musolino C, Pace E, Innao V, Di Salvo E, Ferraro M, Casciaro M, Spatari G, Tartarisco G, Allegra AG, Gangemi S.

Antioxidants (Basel). 2019 Mar 4;8(3). pii: E55. doi: 10.3390/antiox8030055.

11.

The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention.

Allegra A, Innao V, Gerace D, Allegra AG, Vaddinelli D, Bianco O, Musolino C.

Eur J Intern Med. 2018 Jul;53:12-20. doi: 10.1016/j.ejim.2018.05.033. Epub 2018 May 30. Review.

PMID:
29859797
12.

Nanobodies and Cancer: Current Status and New Perspectives.

Allegra A, Innao V, Gerace D, Vaddinelli D, Allegra AG, Musolino C.

Cancer Invest. 2018 Apr 21;36(4):221-237. doi: 10.1080/07357907.2018.1458858. Epub 2018 Apr 16. Review.

PMID:
29658806
13.

Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.

Musolino C, Oteri G, Allegra A, Mania M, D'Ascola A, Avenoso A, Innao V, Allegra AG, Campo S.

Ann Hematol. 2018 Jul;97(7):1259-1269. doi: 10.1007/s00277-018-3296-7. Epub 2018 Mar 15.

PMID:
29546453
14.

Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.

Musolino C, Allegra A, Innao V, Allegra AG, Pioggia G, Gangemi S.

Mediators Inflamm. 2017;2017:1852517. doi: 10.1155/2017/1852517. Epub 2017 Sep 26. Review.

15.

Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma.

Ettari R, Zappalà M, Grasso S, Musolino C, Innao V, Allegra A.

Pharmacol Ther. 2018 Feb;182:176-192. doi: 10.1016/j.pharmthera.2017.09.001. Epub 2017 Sep 11. Review.

PMID:
28911826
16.

Standardisation of minimal residual disease in multiple myeloma.

Innao V, Allegra A, Russo S, Gerace D, Vaddinelli D, Alonci A, Allegra AG, Musolino C.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12732. Epub 2017 Jul 3. Review.

PMID:
28671297
17.

Telomerase and telomere biology in hematological diseases: A new therapeutic target.

Allegra A, Innao V, Penna G, Gerace D, Allegra AG, Musolino C.

Leuk Res. 2017 May;56:60-74. doi: 10.1016/j.leukres.2017.02.002. Epub 2017 Feb 7. Review.

PMID:
28196338
18.

Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient.

Innao V, Allegra A, Morreale R, Russo S, Musolino C.

Turk J Haematol. 2017 Jun 5;34(2):184-185. doi: 10.4274/tjh.2016.0146. Epub 2017 Jan 12. No abstract available.

19.

Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.

Allegra A, Innao V, Russo S, Gerace D, Alonci A, Musolino C.

Cancer Invest. 2017 Jan 2;35(1):1-22. doi: 10.1080/07357907.2016.1247166. Epub 2016 Dec 20. Review.

PMID:
27996308
20.

Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells.

Allegra A, Innao V, Gerace D, Vaddinelli D, Musolino C.

Blood Cells Mol Dis. 2016 Nov;62:49-63. doi: 10.1016/j.bcmd.2016.11.001. Epub 2016 Nov 10. Review.

PMID:
27865176
21.

The metabolomic signature of hematologic malignancies.

Allegra A, Innao V, Gerace D, Bianco O, Musolino C.

Leuk Res. 2016 Oct;49:22-35. doi: 10.1016/j.leukres.2016.08.002. Epub 2016 Aug 8. Review.

PMID:
27526405
22.

Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies.

Aragona P, Allegra A, Postorino EI, Rania L, Innao V, Wylegala E, Nowinska A, Ieni A, Pisani A, Musolino C, Puzzolo D, Micali A.

Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2657-65. doi: 10.1167/iovs.15-18594.

PMID:
27177322
23.

Extramedullary Plasmacytoma of the Maxilla Simulating a Maxillary Radicular Cyst: Quick Diagnosis and Management.

Allegra A, Nastro Siniscalchi E, Cicciù M, Bacci F, Catalfamo L, Innao V, De Ponte FS, Musolino C.

J Craniofac Surg. 2016 May;27(3):e296-7. doi: 10.1097/SCS.0000000000002539.

PMID:
27054435
24.

Vaccination strategies in lymphoproliferative disorders: Failures and successes.

Allegra A, Russo S, Gerace D, Calabrò L, Maisano V, Innao V, Musolino C.

Leuk Res. 2015 Oct;39(10):1006-19. doi: 10.1016/j.leukres.2015.08.001. Epub 2015 Aug 5. Review.

PMID:
26298174
25.

Vaccination of multiple myeloma: Current strategies and future prospects.

Allegra A, Penna G, Innao V, Greve B, Maisano V, Russo S, Musolino C.

Crit Rev Oncol Hematol. 2015 Nov;96(2):339-54. doi: 10.1016/j.critrevonc.2015.06.003. Epub 2015 Jun 18. Review.

PMID:
26123319
26.

The cancer stem cell hypothesis: a guide to potential molecular targets.

Allegra A, Alonci A, Penna G, Innao V, Gerace D, Rotondo F, Musolino C.

Cancer Invest. 2014 Nov;32(9):470-95. doi: 10.3109/07357907.2014.958231. Epub 2014 Sep 25. Review.

PMID:
25254602
27.

New orally active proteasome inhibitors in multiple myeloma.

Allegra A, Alonci A, Gerace D, Russo S, Innao V, Calabrò L, Musolino C.

Leuk Res. 2014 Jan;38(1):1-9. doi: 10.1016/j.leukres.2013.10.018. Epub 2013 Oct 29. Review.

PMID:
24239172
28.

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

Allegra A, Penna G, Alonci A, Russo S, Greve B, Innao V, Minardi V, Musolino C.

Eur J Haematol. 2013 Jun;90(6):441-68. doi: 10.1111/ejh.12107. Epub 2013 Apr 17. Review.

PMID:
23506222
29.

Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease.

Musolino C, Allegra A, Profita M, Alonci A, Saitta S, Russo S, Bonanno A, Innao V, Gangemi S.

Br J Haematol. 2013 Mar;160(5):709-10. doi: 10.1111/bjh.12146. Epub 2012 Dec 4. No abstract available.

PMID:
23205532
30.

A rare pancreatic pseudoaneurysm in patient with acute pancreatitis and multiple myeloma.

Li Destri G, Innao V, Petrillo G, Di Cataldo A.

Ann Ital Chir. 2011 Jul-Aug;82(4):301-4.

PMID:
21834481
31.

Which length for the revision stem?

Toni A, Sudanese A, Bueno Lozano AL, Terzi S, Tabarroni M, Busanelli L, Innao V, Giunti A.

Chir Organi Mov. 1994 Oct-Dec;79(4):319-31. English, Italian.

PMID:
7614871
32.

Femoral bone remodeling: clinical experience with cemented and cementless total hip arthroplasty.

Toni A, Sudanese A, Bueno AL, Marraro MD, Tabarroni M, Innao V, Giunti A.

Chir Organi Mov. 1992 Oct-Dec;77(4):425-31. English, Italian.

PMID:
1297576
33.

Supracondylar process of the humerus: four cases.

Casadei R, Ferraro A, Ferruzzi A, Innao V, Mercuri M.

Chir Organi Mov. 1990 Jul-Sep;75(3):265-77. Review. English, Italian.

PMID:
2095332
34.

[A case of congenital bilateral hip luxation in Ehlers-Danlos syndrome].

Preti P, Stilli S, Innao V.

Chir Organi Mov. 1989 Jul-Dec;74(3-4):155-7. Italian. No abstract available.

PMID:
2635659
35.

[Congenital hypothyroidism (description of a clinical case and review of the literature)].

Calderoni P, Mignani G, Innao V.

Chir Organi Mov. 1988 Oct-Dec;73(4):389-92. Italian. No abstract available.

PMID:
3251713
36.

[Triple pelvic osteotomy in acetabular insufficiency].

Vicenzi G, Moroni A, Assiso J, Toni A, Innao V, Paladini Molgora A, Cantagalli S.

Chir Organi Mov. 1988 Oct-Dec;73(4):307-14. Italian. No abstract available.

PMID:
3251702
37.

[Tibio-peroneal varus osteotomy in genus valgus in the developmental age (study of 87 cases of various etiologies controlled for an average of 8 years)].

Vicenzi G, Moroni A, Ceccarelli F, Innao V, Assiso J.

Chir Organi Mov. 1986 Oct-Dec;71(4):315-23. Italian. No abstract available.

PMID:
3595268
38.

[Multi-fragmented fractures of the patella: osteosynthesis or partial patellectomy?].

Vicenzi G, Ruggieri N, Moroni A, Bettelli G, Innao V.

Chir Organi Mov. 1985 Apr-Jun;70(2):133-40. Italian. No abstract available.

PMID:
3836683
39.

Dysplasia epiphysealis hemimelica. (A review of 19 cases).

Calderoni P, Soncini G, Innao V.

Ital J Orthop Traumatol. 1984 Jun;10(2):243-9.

PMID:
6432738
40.

Pigmented villonodular synovitis of the hip. Study of 9 cases.

Moroni A, Innao V, Picci P.

Ital J Orthop Traumatol. 1983 Sep;9(3):331-7.

PMID:
6662710
41.

The treatment of pulmonary metastases in osteosarcoma. Preliminary observations on 30 cases.

Albisinni U, Briccoli A, Capanna R, Cervellati C, Guernelli N, Guerra A, Innao V.

Ital J Orthop Traumatol. 1983 Sep;9(3):319-23.

PMID:
6582057
42.

Mesenchymal chondrosarcoma of bone and soft tissues.

Bertoni F, Picci P, Bacchini P, Capanna R, Innao V, Bacci G, Campanacci M.

Cancer. 1983 Aug 1;52(3):533-41.

PMID:
6861090
43.

Maffucci's syndrome. Report of 3 cases and review of the literature.

Zocchi D, Innao V, Calderoni P.

Ital J Orthop Traumatol. 1983 Jun;9(2):263-6.

PMID:
6654663
44.

The surgical treatment of bone metastases.

Giunti A, Lijoi F, Innao V.

Ital J Orthop Traumatol. 1982 Sep;8(3):245-55.

PMID:
6186633
45.

Transolecranal dislocations.

Guerra A, Innao V.

Ital J Orthop Traumatol. 1982 Jun;8(2):175-81.

PMID:
7152888
46.

[Fractures of the proximal end of the humerus of surgical importance (study of 40 cases)].

Luppino D, Santangelo G, Vicenzi G, Innao V, Capelli A.

Chir Organi Mov. 1981 Jul-Aug;67(4):373-81. Italian. No abstract available.

PMID:
7349833
47.

[Marfan's syndrome. Further cases at the Rizzoli Orthopedic Institute].

Brillante C, Luppis F, Monterumisi F, Innao V.

Chir Organi Mov. 1980 Jan-Feb;66(1):43-60. Review. Italian. No abstract available.

PMID:
6454546
48.

[An unusual case of bilateral abduction rigidity of the scapulo-humeral joint due to congenital fibrous retraction of the deltoid muscle].

Bachiocco R, Cervellati C, Innao V.

Chir Organi Mov. 1976;63(1):97-101. Italian. No abstract available.

PMID:
1021363
49.

[Post-traumatic ossifications of the elbow and radiotherapy].

Traina GC, Costa P, Innao V.

Chir Organi Mov. 1976;63(1):81-5. Italian. No abstract available.

PMID:
1021361
50.

[Treatment of congenital club-foot during the 1st years of life].

Manes E, Costa CM, Innao V.

Chir Organi Mov. 1975;62(3):301-14. Italian. No abstract available.

PMID:
1222603

Supplemental Content

Support Center